Literature DB >> 10650164

The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice.

T Okamoto1.   

Abstract

Fas ligand, which is a type II membrane protein, is a major inducer of apoptosis. The effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice was studied. Pretreatment of mice with glycyrrhizin (100, 200 and 400 mg/kg, i.p.) inhibited the anti-Fas antibody (150 microg/kg, i.v.)-induced elevation of plasma aminotransferase activity in a dose-dependent manner. CPP32 is a cystein protease and CPP32-like activity induced by anti-Fas antibody injection was inhibited by glycyrrhizin (200 mg/kg). However, the addition of glycyrrhizin (up to 10(-4) M) to a liver cytosol fraction isolated from mice treated with anti-Fas antibodies (150 microg/kg, i.v.) did not inhibit the CPP32-like activity in vitro. The present results clearly show that glycyrrhizin inhibited anti-Fas antibody-induced hepatitis by acting upstream of CPP32-like protease activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10650164     DOI: 10.1016/s0014-2999(99)00807-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice.

Authors:  Hong-Ling Wang; Yu-Xiang Li; Ya-Ting Niu; Jie Zheng; Jing Wu; Guang-Jiang Shi; Lin Ma; Yang Niu; Tao Sun; Jian-Qiang Yu
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 2.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

3.  Effects of minocycline on Fas-mediated fulminant hepatitis in mice.

Authors:  Heng-Cheng Chu; Yi-Ling Lin; Huey-Kang Sytwu; Shin-Hua Lin; Ching-Len Liao; You-Chen Chao
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

4.  Hepatoprotective and antioxidant effects of Glycyrrhiza glabra extract against carbon tetrachloride (CCl(4))-induced hepatocyte damage in common carp (Cyprinus carpio).

Authors:  Guojun Yin; Liping Cao; Pao Xu; Galina Jeney; Miki Nakao; Chengping Lu
Journal:  Fish Physiol Biochem       Date:  2010-09-24       Impact factor: 2.794

5.  Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice.

Authors:  Noriko Tsuruoka; Kazuki Abe; Kenjirou Wake; Masaru Takata; Akira Hatta; Tositugu Sato; Hideo Inoue
Journal:  Inflamm Res       Date:  2009-03-31       Impact factor: 4.575

6.  Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome.

Authors:  Zhiqian Yu; Yuko Ohtaki; Kenzou Kai; Takashi Sasano; Hidetoshi Shimauchi; Takashi Yokochi; Haruhiko Takada; Shunji Sugawara; Katsuo Kumagai; Yasuo Endo
Journal:  Int Immunopharmacol       Date:  2005-03       Impact factor: 4.932

Review 7.  Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.

Authors:  Seidu A Richard
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

8.  Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition.

Authors:  Noriyuki Kuroda; Kouji Inoue; Tadayuki Ikeda; Yaiko Hara; Kenjiro Wake; Tetsuji Sato
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

9.  Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice.

Authors:  Kazuki Abe; Tadayuki Ikeda; Kenjiro Wake; Tetsuji Sato; Toshitsugu Sato; Hideo Inoue
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

10.  Cardioprotective Effect of Monoammonium Glycyrrhizinate Injection Against Myocardial Ischemic Injury in vivo and in vitro: Involvement of Inhibiting Oxidative Stress and Regulating Ca2+ Homeostasis by L-Type Calcium Channels.

Authors:  Zhifeng Zhao; Miaomiao Liu; Yuanyuan Zhang; Yingran Liang; Donglai Ma; Hongfang Wang; Zhihong Ma; Shengjiang Guan; Zhonglin Wu; Xi Chu; Yue Lin; Li Chu
Journal:  Drug Des Devel Ther       Date:  2020-01-23       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.